STOCK TITAN

Spectral AI Inc - MDAIW STOCK NEWS

Welcome to our dedicated page for Spectral AI news (Ticker: MDAIW), a resource for investors and traders seeking the latest updates and insights on Spectral AI stock.

Spectral AI Inc (MDAIW) pioneers AI-driven medical diagnostics through its DeepView System, transforming wound care assessments with real-time imaging technology. This dedicated news hub provides investors and medical professionals with essential updates on the company's advancements in predictive healthcare solutions.

Access authoritative information on regulatory milestones, product developments, and strategic partnerships that shape Spectral AI's position in medical technology. Our curated collection includes press releases about FDA clearances, clinical trial results, and innovations in emergency care diagnostics.

Key updates cover Spectral AI's work with military medical units, enhancements to its proprietary algorithms, and expansions into new healthcare markets. The platform serves as your primary source for understanding how MDAIW's technology improves decision-making in critical care environments.

Bookmark this page for structured access to verified company announcements. Check regularly to stay informed about Spectral AI's contributions to AI-powered diagnostics and their impact on patient outcomes across care settings.

Rhea-AI Summary
Spectral AI, Inc. (Nasdaq: MDAI) will report financial results for Q4 and full year 2023 on March 27, 2024. The company focuses on AI medical diagnostics for wound care. Investors can join the conference call to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Spectral AI, Inc. (MDAI) secures a new $500,000 contract with the Defense Health Agency and the US Army Medical Material Development Activity for the development of the handheld version of DeepView™ Wound Imaging System. The Company has received over $149 million in non-dilutive financing in the past six months, bringing the total government support to over $250 million. The contract aims to optimize the device's functionality and size for combat readiness and potential use in home health care, reinforcing Spectral AI's position as a leader in AI-driven healthcare innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary
Spectral AI, Inc. (Nasdaq: MDAI) forms a subsidiary to focus on advancing intellectual property in the AI healthcare sector, aiming to enhance shareholder value through patents and trade secrets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
Rhea-AI Summary
Spectral AI, Inc. appoints Peter M. Carlson as CEO, transitioning Wensheng Fan to Chief Innovation Strategist. The Company announces preliminary 2023 R&D revenue of $18 million and reaffirms $28 million revenue guidance for 2024. Spectral AI highlights first quarter momentum and key milestones in commercialization of AI-powered wound care technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management AI
-
Rhea-AI Summary
Spectral AI, Inc. (Nasdaq: MDAI) announces participation in investor conferences to showcase their AI technology for medical diagnostics in wound care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences AI
-
Rhea-AI Summary
Spectral AI, Inc. (MDAI) announces the UKCA authorization for its DeepView AI®-Burn predictive software, allowing for faster burn wound diagnosis. Revenue from UK commercialization in 2024 is expected to contribute to the Company's $28 million revenue guidance. The technology boasts 92% accuracy in distinguishing healthy and damaged tissue, potentially revolutionizing burn wound management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Spectral AI, Inc. appoints Dr. J. Michael DiMaio to its Board of Directors, extending lock-up agreements for major stockholders. Dr. DiMaio brings extensive medical and research expertise to support the company's AI-driven wound imaging technology platform.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management AI
-
Rhea-AI Summary
Spectral AI, Inc. (Nasdaq: MDAI) will participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13-14, 2024. The company will host investor meetings during the conference, offering an opportunity for virtual or in-person meetings. This event aims to showcase Spectral AI's focus on medical diagnostics for wound care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences AI
-
Rhea-AI Summary
Spectral AI, Inc. (Nasdaq: MDAI) announced a Letter to Shareholders detailing the Company's progress towards commercializing its AI-driven DeepView System for wound assessment and treatment. The letter highlights a $149 million contract from BARDA, revenue generation expectations, FDA and UKCA marking for proprietary technology, promising interim results for DFU Clinical Study, and new management appointments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
Rhea-AI Summary
Spectral MD, Inc. announces the submission of an application in the UK for its predictive software DeepView AI®-Burn to be registered as UK Conformity Assessed for burn wound use. This marks a significant step towards commercialization for the company's AI software in the medical diagnostics field, specifically for thermal burn wounds.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Spectral AI Inc

Nasdaq:MDAIW

MDAIW Rankings

MDAIW Stock Data

22.60M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
DALLAS